What they were paid
SpringWorks Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | — | — | — | $0 | — |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SpringWorks Therapeutics, Inc. DEF 14A filed April 4, 2025, accession 0001104659-25-032187, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024SpringWorks Therapeutics pays directors a $50,000 cash retainer and $550,000 in Stock Options and RSUs.
Committees
FY2024 · as the proxy prints themAudit · Nominating/Governance
The rest of the SpringWorks Therapeutics board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Alan Fuhrman | Independent Director | $625,239 |
| Carlos Albán | Independent Director | $612,739 |
| Daniel S. Lynch | Independent Director | $650,239 |
| Julie Hambleton | Independent Director | $625,239 |
| Martin Mackay | Independent Director | $1,129,205 |
| Saqib Islam | Director | $0 |
The full SpringWorks Therapeutics compensation record
free company briefThis page is one director within SpringWorks Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat